These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22183554)

  • 1. Using metadynamics and path collective variables to study ligand binding and induced conformational transitions.
    Bešker N; Gervasio FL
    Methods Mol Biol; 2012; 819():501-13. PubMed ID: 22183554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free-energy-based methods for binding profile determination in a congeneric series of CDK2 inhibitors.
    Fidelak J; Juraszek J; Branduardi D; Bianciotto M; Gervasio FL
    J Phys Chem B; 2010 Jul; 114(29):9516-24. PubMed ID: 20593892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Conformational Flexibility on Binding Free Energy Estimation between Kinases and Their Inhibitors.
    Araki M; Kamiya N; Sato M; Nakatsui M; Hirokawa T; Okuno Y
    J Chem Inf Model; 2016 Dec; 56(12):2445-2456. PubMed ID: 28024406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking.
    May A; Zacharias M
    J Med Chem; 2008 Jun; 51(12):3499-506. PubMed ID: 18517186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring ligand binding pathways on proteins using hypersound-accelerated molecular dynamics.
    Araki M; Matsumoto S; Bekker GJ; Isaka Y; Sagae Y; Kamiya N; Okuno Y
    Nat Commun; 2021 May; 12(1):2793. PubMed ID: 33990583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.
    Tian S; Sun H; Pan P; Li D; Zhen X; Li Y; Hou T
    J Chem Inf Model; 2014 Oct; 54(10):2664-79. PubMed ID: 25233367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding.
    Bakan A; Bahar I
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14349-54. PubMed ID: 19706521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.
    Chohan TA; Qian HY; Pan YL; Chen JZ
    Mol Biosyst; 2016 Jan; 12(1):145-61. PubMed ID: 26565382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.
    Rath SL; Senapati S
    PLoS One; 2013; 8(9):e73836. PubMed ID: 24058495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.
    Cholko T; Chen W; Tang Z; Chang CA
    J Comput Aided Mol Des; 2018 Jun; 32(6):671-685. PubMed ID: 29737445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational free energy modeling of druglike molecules by metadynamics in the WHIM space.
    Spiwok V; Hlat-Glembová K; Tvaroška I; Králová B
    J Chem Inf Model; 2012 Mar; 52(3):804-13. PubMed ID: 22360151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate Prediction of Complex Structure and Affinity for a Flexible Protein Receptor and Its Inhibitor.
    Bekker GJ; Kamiya N; Araki M; Fukuda I; Okuno Y; Nakamura H
    J Chem Theory Comput; 2017 Jun; 13(6):2389-2399. PubMed ID: 28482660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors.
    Tripathi SK; Muttineni R; Singh SK
    J Theor Biol; 2013 Oct; 334():87-100. PubMed ID: 23727278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding free energy estimation for protein-ligand complex based on MM-PBSA with various partial charge models.
    Fu T; Jin Z; Xiu Z; Li G
    Curr Pharm Des; 2013; 19(12):2293-307. PubMed ID: 23082979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Accuracy of Protein-Ligand Binding Mode Prediction Using a Molecular Dynamics-Based Pocket Generation Approach.
    Araki M; Iwata H; Ma B; Fujita A; Terayama K; Sagae Y; Ono F; Tsuda K; Kamiya N; Okuno Y
    J Comput Chem; 2018 Dec; 39(32):2679-2689. PubMed ID: 30515903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free-energy landscapes of protein domain movements upon ligand binding.
    Kondo HX; Okimoto N; Morimoto G; Taiji M
    J Phys Chem B; 2011 Jun; 115(23):7629-36. PubMed ID: 21608983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Binding Calculations with Metadynamics.
    Provasi D
    Methods Mol Biol; 2019; 2022():233-253. PubMed ID: 31396906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the Dynamics Landscape of Conformational Transitions in Enzyme: The Adenylate Kinase Case.
    Li D; Liu MS; Ji B
    Biophys J; 2015 Aug; 109(3):647-60. PubMed ID: 26244746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach.
    Tripathi SK; Singh SK; Singh P; Chellaperumal P; Reddy KK; Selvaraj C
    J Mol Recognit; 2012 Oct; 25(10):504-12. PubMed ID: 22996593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.